| Dr Joseph Justis Randolph, MD | |
|
1406 6th Ave N, St Cloud, MN 56303-1901 | |
| (320) 255-5657 | |
| (320) 656-7194 |
| Full Name | Dr Joseph Justis Randolph |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 27 Years |
| Location | 1406 6th Ave N, St Cloud, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164497830 | NPI | - | NPPES |
| 1164497830 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 42563 (Minnesota) | Primary |
| 207P00000X | Emergency Medicine | MD60181938 (Washington) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cuyuna Regional Medical Center | Crosby, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Douglas County Hospital | 0648171413 | 101 |
News Archive
BG Medicine, a life sciences company focused on the discovery, development, and commercialization of novel diagnostics based on biomarkers, today announced the issuance of U.S. Patent No. 7,888,137, entitled "Method For Identifying a Subject at Risk of Developing Heart Failure by Determining the Level of Galectin-3 or Thrombospondin-2" to the University of Maastricht. BG Medicine has an exclusive license to this issued patent, which pertains to galectin-3 testing for individuals at risk for heart failure.
The acid test for a vaccine is: "Does it protect people from infection?" Emory Vaccine Center researchers have analyzed this issue for a leading malaria vaccine called RTS,S, and their results have identified candidate signatures, or biomarkers, in the blood of vaccinated subjects which predict the likelihood of success from vaccination.
A new study out of Carnegie Mellon University reveals that people who regard themselves as humanitarians are even more likely than others to base donations to the poor on whether they believe poverty is a result of bad luck or bad choices.
Taking aim at a leading cause of liver failure in the United States, a team of scientists at the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) has developed a human monoclonal antibody that neutralizes the Hepatitis C virus (HCV).
Bacteriophages, known informally as phages, are viruses that can attack and kill specific bacteria. They occur everywhere in the natural world. Precisely because they are matched to just one specific type of bacteria, researchers and medics hope that phages can be engineered to combat certain bacterial infections.
› Verified 6 days ago
| Entity Name | Unity Family Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326234006 PECOS PAC ID: 9830003516 Enrollment ID: O20031117000732 |
News Archive
BG Medicine, a life sciences company focused on the discovery, development, and commercialization of novel diagnostics based on biomarkers, today announced the issuance of U.S. Patent No. 7,888,137, entitled "Method For Identifying a Subject at Risk of Developing Heart Failure by Determining the Level of Galectin-3 or Thrombospondin-2" to the University of Maastricht. BG Medicine has an exclusive license to this issued patent, which pertains to galectin-3 testing for individuals at risk for heart failure.
The acid test for a vaccine is: "Does it protect people from infection?" Emory Vaccine Center researchers have analyzed this issue for a leading malaria vaccine called RTS,S, and their results have identified candidate signatures, or biomarkers, in the blood of vaccinated subjects which predict the likelihood of success from vaccination.
A new study out of Carnegie Mellon University reveals that people who regard themselves as humanitarians are even more likely than others to base donations to the poor on whether they believe poverty is a result of bad luck or bad choices.
Taking aim at a leading cause of liver failure in the United States, a team of scientists at the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) has developed a human monoclonal antibody that neutralizes the Hepatitis C virus (HCV).
Bacteriophages, known informally as phages, are viruses that can attack and kill specific bacteria. They occur everywhere in the natural world. Precisely because they are matched to just one specific type of bacteria, researchers and medics hope that phages can be engineered to combat certain bacterial infections.
› Verified 6 days ago
| Entity Name | Douglas County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164424305 PECOS PAC ID: 0648171413 Enrollment ID: O20040115000387 |
News Archive
BG Medicine, a life sciences company focused on the discovery, development, and commercialization of novel diagnostics based on biomarkers, today announced the issuance of U.S. Patent No. 7,888,137, entitled "Method For Identifying a Subject at Risk of Developing Heart Failure by Determining the Level of Galectin-3 or Thrombospondin-2" to the University of Maastricht. BG Medicine has an exclusive license to this issued patent, which pertains to galectin-3 testing for individuals at risk for heart failure.
The acid test for a vaccine is: "Does it protect people from infection?" Emory Vaccine Center researchers have analyzed this issue for a leading malaria vaccine called RTS,S, and their results have identified candidate signatures, or biomarkers, in the blood of vaccinated subjects which predict the likelihood of success from vaccination.
A new study out of Carnegie Mellon University reveals that people who regard themselves as humanitarians are even more likely than others to base donations to the poor on whether they believe poverty is a result of bad luck or bad choices.
Taking aim at a leading cause of liver failure in the United States, a team of scientists at the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) has developed a human monoclonal antibody that neutralizes the Hepatitis C virus (HCV).
Bacteriophages, known informally as phages, are viruses that can attack and kill specific bacteria. They occur everywhere in the natural world. Precisely because they are matched to just one specific type of bacteria, researchers and medics hope that phages can be engineered to combat certain bacterial infections.
› Verified 6 days ago
| Entity Name | Cuyuna Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861414518 PECOS PAC ID: 9537146550 Enrollment ID: O20040707000501 |
News Archive
BG Medicine, a life sciences company focused on the discovery, development, and commercialization of novel diagnostics based on biomarkers, today announced the issuance of U.S. Patent No. 7,888,137, entitled "Method For Identifying a Subject at Risk of Developing Heart Failure by Determining the Level of Galectin-3 or Thrombospondin-2" to the University of Maastricht. BG Medicine has an exclusive license to this issued patent, which pertains to galectin-3 testing for individuals at risk for heart failure.
The acid test for a vaccine is: "Does it protect people from infection?" Emory Vaccine Center researchers have analyzed this issue for a leading malaria vaccine called RTS,S, and their results have identified candidate signatures, or biomarkers, in the blood of vaccinated subjects which predict the likelihood of success from vaccination.
A new study out of Carnegie Mellon University reveals that people who regard themselves as humanitarians are even more likely than others to base donations to the poor on whether they believe poverty is a result of bad luck or bad choices.
Taking aim at a leading cause of liver failure in the United States, a team of scientists at the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) has developed a human monoclonal antibody that neutralizes the Hepatitis C virus (HCV).
Bacteriophages, known informally as phages, are viruses that can attack and kill specific bacteria. They occur everywhere in the natural world. Precisely because they are matched to just one specific type of bacteria, researchers and medics hope that phages can be engineered to combat certain bacterial infections.
› Verified 6 days ago
| Entity Name | Unity Family Healthcare |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1780630939 PECOS PAC ID: 9830003516 Enrollment ID: O20061104000248 |
News Archive
BG Medicine, a life sciences company focused on the discovery, development, and commercialization of novel diagnostics based on biomarkers, today announced the issuance of U.S. Patent No. 7,888,137, entitled "Method For Identifying a Subject at Risk of Developing Heart Failure by Determining the Level of Galectin-3 or Thrombospondin-2" to the University of Maastricht. BG Medicine has an exclusive license to this issued patent, which pertains to galectin-3 testing for individuals at risk for heart failure.
The acid test for a vaccine is: "Does it protect people from infection?" Emory Vaccine Center researchers have analyzed this issue for a leading malaria vaccine called RTS,S, and their results have identified candidate signatures, or biomarkers, in the blood of vaccinated subjects which predict the likelihood of success from vaccination.
A new study out of Carnegie Mellon University reveals that people who regard themselves as humanitarians are even more likely than others to base donations to the poor on whether they believe poverty is a result of bad luck or bad choices.
Taking aim at a leading cause of liver failure in the United States, a team of scientists at the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) has developed a human monoclonal antibody that neutralizes the Hepatitis C virus (HCV).
Bacteriophages, known informally as phages, are viruses that can attack and kill specific bacteria. They occur everywhere in the natural world. Precisely because they are matched to just one specific type of bacteria, researchers and medics hope that phages can be engineered to combat certain bacterial infections.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Justis Randolph, MD 1406 6th Ave N, Saint Cloud, MN 56303-1900 Ph: (320) 255-5657 | Dr Joseph Justis Randolph, MD 1406 6th Ave N, St Cloud, MN 56303-1901 Ph: (320) 255-5657 |
News Archive
BG Medicine, a life sciences company focused on the discovery, development, and commercialization of novel diagnostics based on biomarkers, today announced the issuance of U.S. Patent No. 7,888,137, entitled "Method For Identifying a Subject at Risk of Developing Heart Failure by Determining the Level of Galectin-3 or Thrombospondin-2" to the University of Maastricht. BG Medicine has an exclusive license to this issued patent, which pertains to galectin-3 testing for individuals at risk for heart failure.
The acid test for a vaccine is: "Does it protect people from infection?" Emory Vaccine Center researchers have analyzed this issue for a leading malaria vaccine called RTS,S, and their results have identified candidate signatures, or biomarkers, in the blood of vaccinated subjects which predict the likelihood of success from vaccination.
A new study out of Carnegie Mellon University reveals that people who regard themselves as humanitarians are even more likely than others to base donations to the poor on whether they believe poverty is a result of bad luck or bad choices.
Taking aim at a leading cause of liver failure in the United States, a team of scientists at the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) has developed a human monoclonal antibody that neutralizes the Hepatitis C virus (HCV).
Bacteriophages, known informally as phages, are viruses that can attack and kill specific bacteria. They occur everywhere in the natural world. Precisely because they are matched to just one specific type of bacteria, researchers and medics hope that phages can be engineered to combat certain bacterial infections.
› Verified 6 days ago
Daniel Lloyd Fark, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1406 6th Ave N, St Cloud, MN 56303 Phone: 320-255-5657 Fax: 320-656-7194 | |
Peter L Charvat, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1406 6th Ave N, St Cloud Hospital, St Cloud, MN 56303 Phone: 320-255-5656 | |
Anthony P Haas, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1406 6th Ave N, St Cloud Hospital, St Cloud, MN 56303 Phone: 320-255-5657 | |
Mr. John E Mertz, MD PHD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1406 6 Ave N, St Cloud, MN 56301 Phone: 320-255-5657 Fax: 320-656-7194 | |
Michael James Severson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1406 Sixth Ave N, St Cloud, MN 56301 Phone: 320-255-5656 Fax: 320-656-7194 | |
Brett Thomas Stolzenberg, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1406 6th Ave No, St Cloud, MN 56303 Phone: 320-255-5657 Fax: 320-656-7194 |